A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation

被引:229
作者
Lochhead, Pamela A.
Kinstrie, Ross
Sibbet, Gary
Rawjee, Teeara
Morrice, Nick
Cleghon, Vaughn
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland
关键词
D O I
10.1016/j.molcel.2006.10.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen synthase kinase 3 (GSK3), a key component of the insulin and wnt signaling pathways, is unusual, as it is constitutively active and is inhibited in response to upstream signals. Kinase activity is thought to be increased by intramolecular phosphorylation of a tyrosine in the activation loop (Y216 in GSK3 beta), whose timing and mechanism is undefined. We show that GSK3 beta autophosphorylates Y216 as a chaperone-dependent transitional intermediate possessing intramolecular tyrosine kinase activity and displaying different sensitivity to small-molecule inhibitors compared to mature GSK3 beta. After autophosphorylation, mature GSK3 beta is then an intermolecular serine/threonine kinase no longer requiring a chaperone. This shows that autoactivating kinases have adopted different molecular mechanisms for autophosphorylation; and for kinases such as GSK3, inhibitors that affect only the transitional intermediate would be missed in conventional drug screens.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 33 条
[1]   The structure of phosphorylated GSK-3β complexed with a peptide, FRATtide, that inhibits β-catenin phosphorylation [J].
Bax, B ;
Carter, PS ;
Lewis, C ;
Guy, AR ;
Bridges, A ;
Tanner, R ;
Pettman, G ;
Mannix, C ;
Culbert, AA ;
Brown, MJB ;
Smith, DG ;
Reith, AD .
STRUCTURE, 2001, 9 (12) :1143-1152
[2]   Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration [J].
Bhat, RV ;
Shanley, J ;
Correll, MP ;
Fieles, WE ;
Keith, RA ;
Scott, CW ;
Lee, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :11074-11079
[3]   Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription [J].
Coghlan, MP ;
Culbert, AA ;
Cross, DAE ;
Corcoran, SL ;
Yates, JW ;
Pearce, NJ ;
Rausch, OL ;
Murphy, GJ ;
Carter, PS ;
Cox, LR ;
Mills, D ;
Brown, MJ ;
Haigh, D ;
Ward, RW ;
Smith, DG ;
Murray, KJ ;
Reith, AD ;
Holder, JC .
CHEMISTRY & BIOLOGY, 2000, 7 (10) :793-803
[4]   GSK3 inhibitors: Development and therapeutic potential [J].
Cohen, P ;
Goedert, M .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (06) :479-487
[5]   The renaissance of GSK3 [J].
Cohen, P ;
Frame, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :769-776
[6]  
COHEN P, 1978, BIOCH SOC S, V43, P69
[7]   Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event [J].
Cole, A ;
Frame, S ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2004, 377 :249-255
[8]   Thienyl and phenyl α-halomethyl ketones:: New inhibitors of glycogen synthase kinase (GSK-3β) from a library of compound searching [J].
Conde, S ;
Pérez, DI ;
Martínez, A ;
Perez, C ;
Moreno, FJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) :4631-4633
[9]   Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition [J].
Dajani, R ;
Fraser, E ;
Roe, SM ;
Young, N ;
Good, V ;
Dale, TC ;
Pearl, LH .
CELL, 2001, 105 (06) :721-732
[10]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105